NCT04357288Completed
Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 8 Jan 2025
Brief summary (registry, in English)
This study will compare the effectiveness of the use of a Patient Decision Aid (PDA) and an Encounter Decision Aid (EDA) on Shared Decision Making (SDM) and health outcomes for at-risk participants with Atrial Fibrillation (AF) at 6 study sites. We hypothesize the combination of the PDA and EDA will be more effective in promoting high-quality SDM and in adoption of and adherence to anticoagulation than either tool alone.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1117 (actual)
- First submitted
- 13 Apr 2020
- Start date
- Dec 2020
- Primary completion date
- Sept 2024
- Lead sponsor
- University of Utah
- Diseases
- Atrial fibrillation
- NCT number
- NCT04357288
What you commit to
- Study type: Interventional
- Participants enrolled: 1117
- From Dec 2020 to the primary completion date, Sept 2024
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Participants deemed by their clinician or research personnel to be ineligible for consideration of taking or of foregoing anticoagulation
- Have deficits in cognitive abilities or sensory input
- Have a language barrier significant enough to impede shared decision making and/or the provision of written informed consent.
- Clinician Participants -
Who the study is looking for
- Adults (18 and older)
- Are diagnosed with Atrial Fibrillation
- Are aware they have been diagnosed with Atrial Fibrillation
- Participants with additional risk of thromboembolic events (CHA2DS2-VASc scores ≥ 1 in men and ≥ 2 in women)
- 1\. All clinicians (MDs, NP/PAs, PharmDs, APPs, etc.) that are responsible for the modality of Anticoagulation in eligible AF patients at participating sites, without exclusion.
Criteria the registry did not label
- Patient Participants -
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Coordinator of this site? Confirm its status | Ann Arbor | United States | Unknown status |
| University of Alabama at Birmingham Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
| Northwestern University Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
| Vanderbilt University Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
| The Mayo Clinic Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
| University Of Utah Health Coordinator of this site? Confirm its status | Salt Lake City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.